NSC |
Compound |
Enrichment |
Correlation |
NSC 702045 |
2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- |
0.0235234559682125 |
0.47300754 |
NSC 710342 |
4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyophenyl)-5,7-dihydroxy-3,6,8-tris(3-methyl-2-butenyl)- (9CI) |
0.0235234559682125 |
0.2460382 |
NSC 716679 |
Null |
0.0235234559682125 |
0.42153011 |
NSC 723906 |
1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline |
0.0235234559682125 |
0.59979463 |
NSC 724784 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 |
0.0235234559682125 |
0.46976594 |
NSC 671806 |
Null |
0.0235234559682126 |
0.038873113 |
NSC 174121 |
Methotrexate Derivative |
0.0235234559682128 |
0.3876975 |
NSC 117915 |
1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] |
0.0238174255956147 |
0.1055305 |
NSC 123461 |
Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) |
0.0238174255956147 |
0.25216546 |
NSC 123463 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) |
0.0238174255956147 |
0.24804139 |